Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications
Go back to Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications| (NASDAQ: EWTX) | Delayed: 36.81 +1.99 (5.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.82 | 52 Week High | $ | |||
| Open | $35.78 | 52 Week Low | $ | |||
| Day High | $37.14 | P/E | N/A | |||
| Day Low | $35.39 | EPS | $ | |||
| Volume | 2,007,584 | |||||

